Why did Trump remove IRS commissioner quickly?
How will Tesla's Texas robotaxi impact ride-hailing?
What caused Trade Desk's stock to tumble?
Why are gold prices spiking amid tariffs?
How will Trump's tariffs affect global trade?
Why is Apple facing an AI innovation risk?
What’s driving Nvidia's chip export approval to China?
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
benzinga.com/markets/earnings/25/08/46792668/regenerons-pipeline-hit-by-catalent-delays-but-dupixent-shines
On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% year-over-year, beating the consensus of $8.57.
The company reported sales of $3.68 billion, up 4% year over year, beating the consensus of $3.29 billion.
In the…
This story appeared on benzinga.com, 2025-08-01 13:22:46.